APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyanocobalamin API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cyanocobalamin API Market Outlook and Growth Opportunities 2026

31 December 2025190 pages

Choose your research edition.

Industry ResearchCyanocobalamin API Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyanocobalamin API Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cyanocobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyanocobalamin API Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyanocobalamin API Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cyanocobalamin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cyanocobalamin API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cyanocobalamin API market include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyanocobalamin API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyanocobalamin API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyanocobalamin API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyanocobalamin API market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyanocobalamin API Segment by Company

Sanofi

Kingvit

North China Pharmaceutical Group

Hebei Yuxing Bio-Engineering

Hebei Huarong Pharmaceutical

GlaxoSmithKline

Wockhardt

Rochem International

EuroAPI

Bristol Myers Squibb

Basic Nutrition

Antibiotice

Cyanocobalamin API Segment by Type

Crystal

Powder

Cyanocobalamin API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Cyanocobalamin API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cyanocobalamin API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cyanocobalamin API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cyanocobalamin API significant trends, drivers, influence factors in global and regions.

6. To analyze Cyanocobalamin API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyanocobalamin API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyanocobalamin API industry.

Chapter 3: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cyanocobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cyanocobalamin API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cyanocobalamin API Industry Trends Table 2. Cyanocobalamin API Industry Drivers Table 3. Cyanocobalamin API Industry Opportunities and Challenges Table 4. Cyanocobalamin API Industry Restraints Table 5. Global Cyanocobalamin API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cyanocobalamin API Revenue Share by Company (2021-2026) Table 7. Global Cyanocobalamin API Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Cyanocobalamin API Sales Volume Share by Company (2021-2026) Table 9. Global Cyanocobalamin API Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Cyanocobalamin API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cyanocobalamin API Key Company Manufacturing Base & Headquarters Table 12. Global Cyanocobalamin API Company, Product Type & Application Table 13. Global Cyanocobalamin API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyanocobalamin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Crystal Table 18. Significant Companies of Powder Table 19. Global Cyanocobalamin API Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Cyanocobalamin API Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Cyanocobalamin API Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Cyanocobalamin API Sales Volume Share by Type (2021-2026) Table 23. Global Cyanocobalamin API Sales Volume Share by Type (2027-2032) Table 24. Global Cyanocobalamin API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cyanocobalamin API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cyanocobalamin API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cyanocobalamin API Sales Value Share by Type (2021-2026) Table 28. Global Cyanocobalamin API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Contract Manufacturing Organizations Table 30. Significant Companies of Pharmaceutical Companies Table 31. Significant Companies of Others Table 32. Global Cyanocobalamin API Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Cyanocobalamin API Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Cyanocobalamin API Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Cyanocobalamin API Sales Volume Share by Application (2021-2026) Table 36. Global Cyanocobalamin API Sales Volume Share by Application (2027-2032) Table 37. Global Cyanocobalamin API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cyanocobalamin API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Cyanocobalamin API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Cyanocobalamin API Sales Value Share by Application (2021-2026) Table 41. Global Cyanocobalamin API Sales Value Share by Application (2027-2032) Table 42. Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Cyanocobalamin API Sales by Region (2021-2026) & (K Units) Table 44. Global Cyanocobalamin API Sales Market Share by Region (2021-2026) Table 45. Global Cyanocobalamin API Sales by Region (2027-2032) & (K Units) Table 46. Global Cyanocobalamin API Sales Market Share by Region (2027-2032) Table 47. Global Cyanocobalamin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cyanocobalamin API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Cyanocobalamin API Sales Value Share by Region (2021-2026) Table 50. Global Cyanocobalamin API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Cyanocobalamin API Sales Value Share by Region (2027-2032) Table 52. Global Cyanocobalamin API Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Cyanocobalamin API Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Cyanocobalamin API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Cyanocobalamin API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Cyanocobalamin API Sales by Country (2021-2026) & (K Units) Table 57. Global Cyanocobalamin API Sales Market Share by Country (2021-2026) Table 58. Global Cyanocobalamin API Sales by Country (2027-2032) & (K Units) Table 59. Global Cyanocobalamin API Sales Market Share by Country (2027-2032) Table 60. Global Cyanocobalamin API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Cyanocobalamin API Sales Value Market Share by Country (2021-2026) Table 62. Global Cyanocobalamin API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Cyanocobalamin API Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Cyanocobalamin API Product Portfolio Table 68. Sanofi Recent Development Table 69. Kingvit Company Information Table 70. Kingvit Business Overview Table 71. Kingvit Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Kingvit Cyanocobalamin API Product Portfolio Table 73. Kingvit Recent Development Table 74. North China Pharmaceutical Group Company Information Table 75. North China Pharmaceutical Group Business Overview Table 76. North China Pharmaceutical Group Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. North China Pharmaceutical Group Cyanocobalamin API Product Portfolio Table 78. North China Pharmaceutical Group Recent Development Table 79. Hebei Yuxing Bio-Engineering Company Information Table 80. Hebei Yuxing Bio-Engineering Business Overview Table 81. Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio Table 83. Hebei Yuxing Bio-Engineering Recent Development Table 84. Hebei Huarong Pharmaceutical Company Information Table 85. Hebei Huarong Pharmaceutical Business Overview Table 86. Hebei Huarong Pharmaceutical Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio Table 88. Hebei Huarong Pharmaceutical Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Cyanocobalamin API Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Wockhardt Company Information Table 95. Wockhardt Business Overview Table 96. Wockhardt Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Wockhardt Cyanocobalamin API Product Portfolio Table 98. Wockhardt Recent Development Table 99. Rochem International Company Information Table 100. Rochem International Business Overview Table 101. Rochem International Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Rochem International Cyanocobalamin API Product Portfolio Table 103. Rochem International Recent Development Table 104. EuroAPI Company Information Table 105. EuroAPI Business Overview Table 106. EuroAPI Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. EuroAPI Cyanocobalamin API Product Portfolio Table 108. EuroAPI Recent Development Table 109. Bristol Myers Squibb Company Information Table 110. Bristol Myers Squibb Business Overview Table 111. Bristol Myers Squibb Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bristol Myers Squibb Cyanocobalamin API Product Portfolio Table 113. Bristol Myers Squibb Recent Development Table 114. Basic Nutrition Company Information Table 115. Basic Nutrition Business Overview Table 116. Basic Nutrition Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Basic Nutrition Cyanocobalamin API Product Portfolio Table 118. Basic Nutrition Recent Development Table 119. Antibiotice Company Information Table 120. Antibiotice Business Overview Table 121. Antibiotice Cyanocobalamin API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Antibiotice Cyanocobalamin API Product Portfolio Table 123. Antibiotice Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Cyanocobalamin API Distributors List Table 127. Cyanocobalamin API Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Cyanocobalamin API Product Image Figure 2. Global Cyanocobalamin API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cyanocobalamin API Sales (2021-2032) & (K Units) Figure 5. Global Cyanocobalamin API Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Cyanocobalamin API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Crystal Image Figure 10. Powder Image Figure 11. Global Cyanocobalamin API Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Cyanocobalamin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cyanocobalamin API Sales Volume Share by Type (2021-2032) Figure 14. Global Cyanocobalamin API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cyanocobalamin API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cyanocobalamin API Sales Value Share by Type (2021-2032) Figure 17. Contract Manufacturing Organizations Image Figure 18. Pharmaceutical Companies Image Figure 19. Others Image Figure 20. Global Cyanocobalamin API Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Cyanocobalamin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Cyanocobalamin API Sales Volume Share by Application (2021-2032) Figure 23. Global Cyanocobalamin API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cyanocobalamin API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Cyanocobalamin API Sales Value Share by Application (2021-2032) Figure 26. Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Cyanocobalamin API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Cyanocobalamin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cyanocobalamin API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cyanocobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cyanocobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cyanocobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cyanocobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cyanocobalamin API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cyanocobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cyanocobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Cyanocobalamin API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Cyanocobalamin API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Crystal
  • Powder
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • Sanofi
  • Kingvit
  • North China Pharmaceutical Group
  • Hebei Yuxing Bio-Engineering
  • Hebei Huarong Pharmaceutical
  • GlaxoSmithKline
  • Wockhardt
  • Rochem International
  • EuroAPI
  • Bristol Myers Squibb
  • Basic Nutrition
  • Antibiotice

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyanocobalamin API Sales Value (2021-2032)
  4. 1.2.2 Global Cyanocobalamin API Sales Volume (2021-2032)
  5. 1.2.3 Global Cyanocobalamin API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cyanocobalamin API Market Dynamics
  1. 2.1 Cyanocobalamin API Industry Trends
  2. 2.2 Cyanocobalamin API Industry Drivers
  3. 2.3 Cyanocobalamin API Industry Opportunities and Challenges
  4. 2.4 Cyanocobalamin API Industry Restraints
3 Cyanocobalamin API Market by Company
  1. 3.1 Global Cyanocobalamin API Company Revenue Ranking in 2025
  2. 3.2 Global Cyanocobalamin API Revenue by Company (2021-2026)
  3. 3.3 Global Cyanocobalamin API Sales Volume by Company (2021-2026)
  4. 3.4 Global Cyanocobalamin API Average Price by Company (2021-2026)
  5. 3.5 Global Cyanocobalamin API Company Ranking (2024-2026)
  6. 3.6 Global Cyanocobalamin API Company Manufacturing Base and Headquarters
  7. 3.7 Global Cyanocobalamin API Company Product Type and Application
  8. 3.8 Global Cyanocobalamin API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cyanocobalamin API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cyanocobalamin API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cyanocobalamin API Market by Type
  1. 4.1 Cyanocobalamin API Type Introduction
  2. 4.1.1 Crystal
  3. 4.1.2 Powder
  4. 4.2 Global Cyanocobalamin API Sales Volume by Type
  5. 4.2.1 Global Cyanocobalamin API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyanocobalamin API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cyanocobalamin API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cyanocobalamin API Sales Value by Type
  9. 4.3.1 Global Cyanocobalamin API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyanocobalamin API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cyanocobalamin API Sales Value Share by Type (2021-2032)
5 Cyanocobalamin API Market by Application
  1. 5.1 Cyanocobalamin API Application Introduction
  2. 5.1.1 Contract Manufacturing Organizations
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Cyanocobalamin API Sales Volume by Application
  6. 5.2.1 Global Cyanocobalamin API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyanocobalamin API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cyanocobalamin API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cyanocobalamin API Sales Value by Application
  10. 5.3.1 Global Cyanocobalamin API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyanocobalamin API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cyanocobalamin API Sales Value Share by Application (2021-2032)
6 Cyanocobalamin API Regional Sales and Value Analysis
  1. 6.1 Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyanocobalamin API Sales by Region (2021-2032)
  3. 6.2.1 Global Cyanocobalamin API Sales by Region: 2021-2026
  4. 6.2.2 Global Cyanocobalamin API Sales by Region (2027-2032)
  5. 6.3 Global Cyanocobalamin API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cyanocobalamin API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cyanocobalamin API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cyanocobalamin API Sales Value by Region (2027-2032)
  9. 6.5 Global Cyanocobalamin API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cyanocobalamin API Sales Value (2021-2032)
  12. 6.6.2 North America Cyanocobalamin API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cyanocobalamin API Sales Value (2021-2032)
  15. 6.7.2 Europe Cyanocobalamin API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cyanocobalamin API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cyanocobalamin API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cyanocobalamin API Sales Value (2021-2032)
  21. 6.9.2 South America Cyanocobalamin API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cyanocobalamin API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cyanocobalamin API Sales Value Share by Country, 2025 VS 2032
7 Cyanocobalamin API Country-level Sales and Value Analysis
  1. 7.1 Global Cyanocobalamin API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyanocobalamin API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cyanocobalamin API Sales by Country (2021-2032)
  4. 7.3.1 Global Cyanocobalamin API Sales by Country (2021-2026)
  5. 7.3.2 Global Cyanocobalamin API Sales by Country (2027-2032)
  6. 7.4 Global Cyanocobalamin API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cyanocobalamin API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cyanocobalamin API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cyanocobalamin API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cyanocobalamin API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cyanocobalamin API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Cyanocobalamin API Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Kingvit
  8. 8.2.1 Kingvit Company Information
  9. 8.2.2 Kingvit Business Overview
  10. 8.2.3 Kingvit Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kingvit Cyanocobalamin API Product Portfolio
  12. 8.2.5 Kingvit Recent Developments
  13. 8.3 North China Pharmaceutical Group
  14. 8.3.1 North China Pharmaceutical Group Company Information
  15. 8.3.2 North China Pharmaceutical Group Business Overview
  16. 8.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
  18. 8.3.5 North China Pharmaceutical Group Recent Developments
  19. 8.4 Hebei Yuxing Bio-Engineering
  20. 8.4.1 Hebei Yuxing Bio-Engineering Company Information
  21. 8.4.2 Hebei Yuxing Bio-Engineering Business Overview
  22. 8.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
  24. 8.4.5 Hebei Yuxing Bio-Engineering Recent Developments
  25. 8.5 Hebei Huarong Pharmaceutical
  26. 8.5.1 Hebei Huarong Pharmaceutical Company Information
  27. 8.5.2 Hebei Huarong Pharmaceutical Business Overview
  28. 8.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
  30. 8.5.5 Hebei Huarong Pharmaceutical Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Wockhardt
  38. 8.7.1 Wockhardt Company Information
  39. 8.7.2 Wockhardt Business Overview
  40. 8.7.3 Wockhardt Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wockhardt Cyanocobalamin API Product Portfolio
  42. 8.7.5 Wockhardt Recent Developments
  43. 8.8 Rochem International
  44. 8.8.1 Rochem International Company Information
  45. 8.8.2 Rochem International Business Overview
  46. 8.8.3 Rochem International Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rochem International Cyanocobalamin API Product Portfolio
  48. 8.8.5 Rochem International Recent Developments
  49. 8.9 EuroAPI
  50. 8.9.1 EuroAPI Company Information
  51. 8.9.2 EuroAPI Business Overview
  52. 8.9.3 EuroAPI Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 EuroAPI Cyanocobalamin API Product Portfolio
  54. 8.9.5 EuroAPI Recent Developments
  55. 8.10 Bristol Myers Squibb
  56. 8.10.1 Bristol Myers Squibb Company Information
  57. 8.10.2 Bristol Myers Squibb Business Overview
  58. 8.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
  60. 8.10.5 Bristol Myers Squibb Recent Developments
  61. 8.11 Basic Nutrition
  62. 8.11.1 Basic Nutrition Company Information
  63. 8.11.2 Basic Nutrition Business Overview
  64. 8.11.3 Basic Nutrition Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
  66. 8.11.5 Basic Nutrition Recent Developments
  67. 8.12 Antibiotice
  68. 8.12.1 Antibiotice Company Information
  69. 8.12.2 Antibiotice Business Overview
  70. 8.12.3 Antibiotice Cyanocobalamin API Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Antibiotice Cyanocobalamin API Product Portfolio
  72. 8.12.5 Antibiotice Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyanocobalamin API Value Chain Analysis
  2. 9.1.1 Cyanocobalamin API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyanocobalamin API Sales Mode & Process
  6. 9.2 Cyanocobalamin API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyanocobalamin API Distributors
  9. 9.2.3 Cyanocobalamin API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst